NeoX combines AI with biophysics for drug R&D, focusing on macromolecular drugs and multispecific drugs, especially in the field of immuno-oncology.
neoX
Close
AI/Computing-Driven TherapeuticsArtificial IntelligenceBiotechnology
Michael Chen
Founder and CEO